Are 'great' tweeters born? Or can they be made? A conversation with Adam Feuerstein.
If you’re a drug development professional with ambition, you can’t afford to ignore Twitter. No matter your opinion of Twitter as a company, the act of tweeting is here to say: short, public, one-to-many communication is never being put back in the bottle. I’ve written about this issue before, offering a list of 300 accounts known to tweet biopharma-related news fastest. Maintaining a good list of followed accounts, consuming your news directly from the source, exposing yourself to a diversity of opinion outside your comfort zone: that’s BioTwitter 101, the minimum relationship a drug developer ought to have with social media. There’s no excuse to dismiss all social media with a wide brush of this doesn’t apply to me. You don’t have to tweet to be good at Twitter.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.